1 Study Coverage
    1.1 Nuclear Medicine Radioisotopes Product Introduction
    1.2 Market by Type
        1.2.1 Global Nuclear Medicine Radioisotopes Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Thallium-201 (Tl-201)
        1.2.3 Iodine (I-123)
        1.2.4 Fluorine-18
        1.2.5 Rubidium-82 (Rb-82)
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Nuclear Medicine Radioisotopes Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Tumor
        1.3.3 Heart Disease
        1.3.4 Lymphoma
        1.3.5 Thyroid Gland
        1.3.6 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Nuclear Medicine Radioisotopes Sales Estimates and Forecasts 2017-2028
    2.2 Global Nuclear Medicine Radioisotopes Revenue Estimates and Forecasts 2017-2028
    2.3 Global Nuclear Medicine Radioisotopes Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Nuclear Medicine Radioisotopes Sales by Region
        2.4.1 Global Nuclear Medicine Radioisotopes Sales by Region (2017-2022)
        2.4.2 Global Sales Nuclear Medicine Radioisotopes by Region (2023-2028)
    2.5 Global Nuclear Medicine Radioisotopes Revenue by Region
        2.5.1 Global Nuclear Medicine Radioisotopes Revenue by Region (2017-2022)
        2.5.2 Global Nuclear Medicine Radioisotopes Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Nuclear Medicine Radioisotopes Sales by Manufacturers
        3.1.1 Global Top Nuclear Medicine Radioisotopes Manufacturers by Sales (2017-2022)
        3.1.2 Global Nuclear Medicine Radioisotopes Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nuclear Medicine Radioisotopes in 2021
    3.2 Global Nuclear Medicine Radioisotopes Revenue by Manufacturers
        3.2.1 Global Nuclear Medicine Radioisotopes Revenue by Manufacturers (2017-2022)
        3.2.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Nuclear Medicine Radioisotopes Revenue in 2021
    3.3 Global Nuclear Medicine Radioisotopes Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Nuclear Medicine Radioisotopes Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Nuclear Medicine Radioisotopes Sales by Type
        4.1.1 Global Nuclear Medicine Radioisotopes Historical Sales by Type (2017-2022)
        4.1.2 Global Nuclear Medicine Radioisotopes Forecasted Sales by Type (2023-2028)
        4.1.3 Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2017-2028)
    4.2 Global Nuclear Medicine Radioisotopes Revenue by Type
        4.2.1 Global Nuclear Medicine Radioisotopes Historical Revenue by Type (2017-2022)
        4.2.2 Global Nuclear Medicine Radioisotopes Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2017-2028)
    4.3 Global Nuclear Medicine Radioisotopes Price by Type
        4.3.1 Global Nuclear Medicine Radioisotopes Price by Type (2017-2022)
        4.3.2 Global Nuclear Medicine Radioisotopes Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Nuclear Medicine Radioisotopes Sales by Application
        5.1.1 Global Nuclear Medicine Radioisotopes Historical Sales by Application (2017-2022)
        5.1.2 Global Nuclear Medicine Radioisotopes Forecasted Sales by Application (2023-2028)
        5.1.3 Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2017-2028)
    5.2 Global Nuclear Medicine Radioisotopes Revenue by Application
        5.2.1 Global Nuclear Medicine Radioisotopes Historical Revenue by Application (2017-2022)
        5.2.2 Global Nuclear Medicine Radioisotopes Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Nuclear Medicine Radioisotopes Revenue Market Share by Application (2017-2028)
    5.3 Global Nuclear Medicine Radioisotopes Price by Application
        5.3.1 Global Nuclear Medicine Radioisotopes Price by Application (2017-2022)
        5.3.2 Global Nuclear Medicine Radioisotopes Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Nuclear Medicine Radioisotopes Market Size by Type
        6.1.1 North America Nuclear Medicine Radioisotopes Sales by Type (2017-2028)
        6.1.2 North America Nuclear Medicine Radioisotopes Revenue by Type (2017-2028)
    6.2 North America Nuclear Medicine Radioisotopes Market Size by Application
        6.2.1 North America Nuclear Medicine Radioisotopes Sales by Application (2017-2028)
        6.2.2 North America Nuclear Medicine Radioisotopes Revenue by Application (2017-2028)
    6.3 North America Nuclear Medicine Radioisotopes Market Size by Country
        6.3.1 North America Nuclear Medicine Radioisotopes Sales by Country (2017-2028)
        6.3.2 North America Nuclear Medicine Radioisotopes Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Nuclear Medicine Radioisotopes Market Size by Type
        7.1.1 Europe Nuclear Medicine Radioisotopes Sales by Type (2017-2028)
        7.1.2 Europe Nuclear Medicine Radioisotopes Revenue by Type (2017-2028)
    7.2 Europe Nuclear Medicine Radioisotopes Market Size by Application
        7.2.1 Europe Nuclear Medicine Radioisotopes Sales by Application (2017-2028)
        7.2.2 Europe Nuclear Medicine Radioisotopes Revenue by Application (2017-2028)
    7.3 Europe Nuclear Medicine Radioisotopes Market Size by Country
        7.3.1 Europe Nuclear Medicine Radioisotopes Sales by Country (2017-2028)
        7.3.2 Europe Nuclear Medicine Radioisotopes Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Nuclear Medicine Radioisotopes Market Size by Type
        8.1.1 Asia Pacific Nuclear Medicine Radioisotopes Sales by Type (2017-2028)
        8.1.2 Asia Pacific Nuclear Medicine Radioisotopes Revenue by Type (2017-2028)
    8.2 Asia Pacific Nuclear Medicine Radioisotopes Market Size by Application
        8.2.1 Asia Pacific Nuclear Medicine Radioisotopes Sales by Application (2017-2028)
        8.2.2 Asia Pacific Nuclear Medicine Radioisotopes Revenue by Application (2017-2028)
    8.3 Asia Pacific Nuclear Medicine Radioisotopes Market Size by Region
        8.3.1 Asia Pacific Nuclear Medicine Radioisotopes Sales by Region (2017-2028)
        8.3.2 Asia Pacific Nuclear Medicine Radioisotopes Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Nuclear Medicine Radioisotopes Market Size by Type
        9.1.1 Latin America Nuclear Medicine Radioisotopes Sales by Type (2017-2028)
        9.1.2 Latin America Nuclear Medicine Radioisotopes Revenue by Type (2017-2028)
    9.2 Latin America Nuclear Medicine Radioisotopes Market Size by Application
        9.2.1 Latin America Nuclear Medicine Radioisotopes Sales by Application (2017-2028)
        9.2.2 Latin America Nuclear Medicine Radioisotopes Revenue by Application (2017-2028)
    9.3 Latin America Nuclear Medicine Radioisotopes Market Size by Country
        9.3.1 Latin America Nuclear Medicine Radioisotopes Sales by Country (2017-2028)
        9.3.2 Latin America Nuclear Medicine Radioisotopes Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Nuclear Medicine Radioisotopes Market Size by Type
        10.1.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Type (2017-2028)
    10.2 Middle East and Africa Nuclear Medicine Radioisotopes Market Size by Application
        10.2.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Application (2017-2028)
    10.3 Middle East and Africa Nuclear Medicine Radioisotopes Market Size by Country
        10.3.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Agfa-Gevaert Group
        11.1.1 Agfa-Gevaert Group Corporation Information
        11.1.2 Agfa-Gevaert Group Overview
        11.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Agfa-Gevaert Group Recent Developments
    11.2 Braco
        11.2.1 Braco Corporation Information
        11.2.2 Braco Overview
        11.2.3 Braco Nuclear Medicine Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Braco Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Braco Recent Developments
    11.3 Cardiarc
        11.3.1 Cardiarc Corporation Information
        11.3.2 Cardiarc Overview
        11.3.3 Cardiarc Nuclear Medicine Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Cardiarc Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Cardiarc Recent Developments
    11.4 Cardinal Health
        11.4.1 Cardinal Health Corporation Information
        11.4.2 Cardinal Health Overview
        11.4.3 Cardinal Health Nuclear Medicine Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Cardinal Health Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Cardinal Health Recent Developments
    11.5 CMR Naviscan (Gamma Medica Inc.)
        11.5.1 CMR Naviscan (Gamma Medica Inc.) Corporation Information
        11.5.2 CMR Naviscan (Gamma Medica Inc.) Overview
        11.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 CMR Naviscan (Gamma Medica Inc.) Recent Developments
    11.6 Curium
        11.6.1 Curium Corporation Information
        11.6.2 Curium Overview
        11.6.3 Curium Nuclear Medicine Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Curium Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Curium Recent Developments
    11.7 Digirad
        11.7.1 Digirad Corporation Information
        11.7.2 Digirad Overview
        11.7.3 Digirad Nuclear Medicine Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Digirad Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Digirad Recent Developments
    11.8 GE Healthcare
        11.8.1 GE Healthcare Corporation Information
        11.8.2 GE Healthcare Overview
        11.8.3 GE Healthcare Nuclear Medicine Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 GE Healthcare Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 GE Healthcare Recent Developments
    11.9 Nordion (Canada)
        11.9.1 Nordion (Canada) Corporation Information
        11.9.2 Nordion (Canada) Overview
        11.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Nordion (Canada) Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Nordion (Canada) Recent Developments
    11.10 NTP Radioisotopes SOC
        11.10.1 NTP Radioisotopes SOC Corporation Information
        11.10.2 NTP Radioisotopes SOC Overview
        11.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 NTP Radioisotopes SOC Recent Developments
    11.11 Positron
        11.11.1 Positron Corporation Information
        11.11.2 Positron Overview
        11.11.3 Positron Nuclear Medicine Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Positron Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Positron Recent Developments
    11.12 Segami
        11.12.1 Segami Corporation Information
        11.12.2 Segami Overview
        11.12.3 Segami Nuclear Medicine Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Segami Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Segami Recent Developments
    11.13 Siemens Healthcare
        11.13.1 Siemens Healthcare Corporation Information
        11.13.2 Siemens Healthcare Overview
        11.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Siemens Healthcare Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Siemens Healthcare Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Nuclear Medicine Radioisotopes Industry Chain Analysis
    12.2 Nuclear Medicine Radioisotopes Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Nuclear Medicine Radioisotopes Production Mode & Process
    12.4 Nuclear Medicine Radioisotopes Sales and Marketing
        12.4.1 Nuclear Medicine Radioisotopes Sales Channels
        12.4.2 Nuclear Medicine Radioisotopes Distributors
    12.5 Nuclear Medicine Radioisotopes Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Nuclear Medicine Radioisotopes Industry Trends
    13.2 Nuclear Medicine Radioisotopes Market Drivers
    13.3 Nuclear Medicine Radioisotopes Market Challenges
    13.4 Nuclear Medicine Radioisotopes Market Restraints
14 Key Findings in The Global Nuclear Medicine Radioisotopes Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Nuclear Medicine Radioisotopes Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Thallium-201 (Tl-201)
    Table 3. Major Manufacturers of Iodine (I-123)
    Table 4. Major Manufacturers of Fluorine-18
    Table 5. Major Manufacturers of Rubidium-82 (Rb-82)
    Table 6. Major Manufacturers of Other
    Table 7. Global Nuclear Medicine Radioisotopes Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Nuclear Medicine Radioisotopes Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Nuclear Medicine Radioisotopes Sales by Region (2017-2022) & (K Units)
    Table 10. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2017-2022)
    Table 11. Global Nuclear Medicine Radioisotopes Sales by Region (2023-2028) & (K Units)
    Table 12. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2023-2028)
    Table 13. Global Nuclear Medicine Radioisotopes Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Nuclear Medicine Radioisotopes Revenue Market Share by Region (2017-2022)
    Table 15. Global Nuclear Medicine Radioisotopes Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Nuclear Medicine Radioisotopes Revenue Market Share by Region (2023-2028)
    Table 17. Global Nuclear Medicine Radioisotopes Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Nuclear Medicine Radioisotopes Sales Share by Manufacturers (2017-2022)
    Table 19. Global Nuclear Medicine Radioisotopes Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Nuclear Medicine Radioisotopes Revenue Share by Manufacturers (2017-2022)
    Table 21. Nuclear Medicine Radioisotopes Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global Nuclear Medicine Radioisotopes Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Nuclear Medicine Radioisotopes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Radioisotopes as of 2021)
    Table 24. Nuclear Medicine Radioisotopes Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Nuclear Medicine Radioisotopes Product Offered
    Table 26. Date of Manufacturers Enter into Nuclear Medicine Radioisotopes Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Nuclear Medicine Radioisotopes Sales by Type (2017-2022) & (K Units)
    Table 29. Global Nuclear Medicine Radioisotopes Sales by Type (2023-2028) & (K Units)
    Table 30. Global Nuclear Medicine Radioisotopes Sales Share by Type (2017-2022)
    Table 31. Global Nuclear Medicine Radioisotopes Sales Share by Type (2023-2028)
    Table 32. Global Nuclear Medicine Radioisotopes Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Nuclear Medicine Radioisotopes Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Nuclear Medicine Radioisotopes Revenue Share by Type (2017-2022)
    Table 35. Global Nuclear Medicine Radioisotopes Revenue Share by Type (2023-2028)
    Table 36. Nuclear Medicine Radioisotopes Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global Nuclear Medicine Radioisotopes Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global Nuclear Medicine Radioisotopes Sales by Application (2017-2022) & (K Units)
    Table 39. Global Nuclear Medicine Radioisotopes Sales by Application (2023-2028) & (K Units)
    Table 40. Global Nuclear Medicine Radioisotopes Sales Share by Application (2017-2022)
    Table 41. Global Nuclear Medicine Radioisotopes Sales Share by Application (2023-2028)
    Table 42. Global Nuclear Medicine Radioisotopes Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Nuclear Medicine Radioisotopes Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Nuclear Medicine Radioisotopes Revenue Share by Application (2017-2022)
    Table 45. Global Nuclear Medicine Radioisotopes Revenue Share by Application (2023-2028)
    Table 46. Nuclear Medicine Radioisotopes Price by Application (2017-2022) & (USD/Unit)
    Table 47. Global Nuclear Medicine Radioisotopes Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 48. North America Nuclear Medicine Radioisotopes Sales by Type (2017-2022) & (K Units)
    Table 49. North America Nuclear Medicine Radioisotopes Sales by Type (2023-2028) & (K Units)
    Table 50. North America Nuclear Medicine Radioisotopes Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Nuclear Medicine Radioisotopes Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Nuclear Medicine Radioisotopes Sales by Application (2017-2022) & (K Units)
    Table 53. North America Nuclear Medicine Radioisotopes Sales by Application (2023-2028) & (K Units)
    Table 54. North America Nuclear Medicine Radioisotopes Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Nuclear Medicine Radioisotopes Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Nuclear Medicine Radioisotopes Sales by Country (2017-2022) & (K Units)
    Table 57. North America Nuclear Medicine Radioisotopes Sales by Country (2023-2028) & (K Units)
    Table 58. North America Nuclear Medicine Radioisotopes Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Nuclear Medicine Radioisotopes Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Nuclear Medicine Radioisotopes Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Nuclear Medicine Radioisotopes Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Nuclear Medicine Radioisotopes Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Nuclear Medicine Radioisotopes Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Nuclear Medicine Radioisotopes Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Nuclear Medicine Radioisotopes Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Nuclear Medicine Radioisotopes Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Nuclear Medicine Radioisotopes Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Nuclear Medicine Radioisotopes Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Nuclear Medicine Radioisotopes Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Nuclear Medicine Radioisotopes Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Nuclear Medicine Radioisotopes Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Nuclear Medicine Radioisotopes Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Nuclear Medicine Radioisotopes Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Nuclear Medicine Radioisotopes Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Nuclear Medicine Radioisotopes Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Nuclear Medicine Radioisotopes Sales by Application (2017-2022) & (K Units)
    Table 77. Asia Pacific Nuclear Medicine Radioisotopes Sales by Application (2023-2028) & (K Units)
    Table 78. Asia Pacific Nuclear Medicine Radioisotopes Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Nuclear Medicine Radioisotopes Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Nuclear Medicine Radioisotopes Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Nuclear Medicine Radioisotopes Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Nuclear Medicine Radioisotopes Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Nuclear Medicine Radioisotopes Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Nuclear Medicine Radioisotopes Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Nuclear Medicine Radioisotopes Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Nuclear Medicine Radioisotopes Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Nuclear Medicine Radioisotopes Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Nuclear Medicine Radioisotopes Sales by Application (2017-2022) & (K Units)
    Table 89. Latin America Nuclear Medicine Radioisotopes Sales by Application (2023-2028) & (K Units)
    Table 90. Latin America Nuclear Medicine Radioisotopes Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Nuclear Medicine Radioisotopes Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Nuclear Medicine Radioisotopes Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Nuclear Medicine Radioisotopes Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Nuclear Medicine Radioisotopes Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Nuclear Medicine Radioisotopes Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Nuclear Medicine Radioisotopes Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Nuclear Medicine Radioisotopes Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Nuclear Medicine Radioisotopes Sales by Application (2017-2022) & (K Units)
    Table 101. Middle East and Africa Nuclear Medicine Radioisotopes Sales by Application (2023-2028) & (K Units)
    Table 102. Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Nuclear Medicine Radioisotopes Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Nuclear Medicine Radioisotopes Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Agfa-Gevaert Group Corporation Information
    Table 109. Agfa-Gevaert Group Description and Major Businesses
    Table 110. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Agfa-Gevaert Group Recent Developments
    Table 113. Braco Corporation Information
    Table 114. Braco Description and Major Businesses
    Table 115. Braco Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. Braco Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Braco Recent Developments
    Table 118. Cardiarc Corporation Information
    Table 119. Cardiarc Description and Major Businesses
    Table 120. Cardiarc Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. Cardiarc Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Cardiarc Recent Developments
    Table 123. Cardinal Health Corporation Information
    Table 124. Cardinal Health Description and Major Businesses
    Table 125. Cardinal Health Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. Cardinal Health Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Cardinal Health Recent Developments
    Table 128. CMR Naviscan (Gamma Medica Inc.) Corporation Information
    Table 129. CMR Naviscan (Gamma Medica Inc.) Description and Major Businesses
    Table 130. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 131. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. CMR Naviscan (Gamma Medica Inc.) Recent Developments
    Table 133. Curium Corporation Information
    Table 134. Curium Description and Major Businesses
    Table 135. Curium Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 136. Curium Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Curium Recent Developments
    Table 138. Digirad Corporation Information
    Table 139. Digirad Description and Major Businesses
    Table 140. Digirad Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 141. Digirad Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Digirad Recent Developments
    Table 143. GE Healthcare Corporation Information
    Table 144. GE Healthcare Description and Major Businesses
    Table 145. GE Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 146. GE Healthcare Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. GE Healthcare Recent Developments
    Table 148. Nordion (Canada) Corporation Information
    Table 149. Nordion (Canada) Description and Major Businesses
    Table 150. Nordion (Canada) Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 151. Nordion (Canada) Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Nordion (Canada) Recent Developments
    Table 153. NTP Radioisotopes SOC Corporation Information
    Table 154. NTP Radioisotopes SOC Description and Major Businesses
    Table 155. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 156. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. NTP Radioisotopes SOC Recent Developments
    Table 158. Positron Corporation Information
    Table 159. Positron Description and Major Businesses
    Table 160. Positron Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 161. Positron Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Positron Recent Developments
    Table 163. Segami Corporation Information
    Table 164. Segami Description and Major Businesses
    Table 165. Segami Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 166. Segami Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Segami Recent Developments
    Table 168. Siemens Healthcare Corporation Information
    Table 169. Siemens Healthcare Description and Major Businesses
    Table 170. Siemens Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 171. Siemens Healthcare Nuclear Medicine Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Siemens Healthcare Recent Developments
    Table 173. Key Raw Materials Lists
    Table 174. Raw Materials Key Suppliers Lists
    Table 175. Nuclear Medicine Radioisotopes Distributors List
    Table 176. Nuclear Medicine Radioisotopes Customers List
    Table 177. Nuclear Medicine Radioisotopes Market Trends
    Table 178. Nuclear Medicine Radioisotopes Market Drivers
    Table 179. Nuclear Medicine Radioisotopes Market Challenges
    Table 180. Nuclear Medicine Radioisotopes Market Restraints
    Table 181. Research Programs/Design for This Report
    Table 182. Key Data Information from Secondary Sources
    Table 183. Key Data Information from Primary Sources
List of Figures
    Figure 1. Nuclear Medicine Radioisotopes Product Picture
    Figure 3. Global Nuclear Medicine Radioisotopes Market Share by Type in 2021 & 2028
    Figure 3. Thallium-201 (Tl-201) Product Picture
    Figure 4. Iodine (I-123) Product Picture
    Figure 5. Fluorine-18 Product Picture
    Figure 6. Rubidium-82 (Rb-82) Product Picture
    Figure 7. Other Product Picture
    Figure 8. Global Nuclear Medicine Radioisotopes Market Share by Application in 2021 & 2028
    Figure 9. Tumor
    Figure 10. Heart Disease
    Figure 11. Lymphoma
    Figure 12. Thyroid Gland
    Figure 13. Other
    Figure 14. Nuclear Medicine Radioisotopes Report Years Considered
    Figure 15. Global Nuclear Medicine Radioisotopes Sales 2017-2028 (K Units)
    Figure 16. Global Nuclear Medicine Radioisotopes Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Nuclear Medicine Radioisotopes Revenue 2017-2028 (US$ Million)
    Figure 18. Global Nuclear Medicine Radioisotopes Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 19. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2017-2022)
    Figure 20. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2023-2028)
    Figure 21. North America Nuclear Medicine Radioisotopes Sales YoY (2017-2028) & (K Units)
    Figure 22. North America Nuclear Medicine Radioisotopes Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Nuclear Medicine Radioisotopes Sales YoY (2017-2028) & (K Units)
    Figure 24. Europe Nuclear Medicine Radioisotopes Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Asia-Pacific Nuclear Medicine Radioisotopes Sales YoY (2017-2028) & (K Units)
    Figure 26. Asia-Pacific Nuclear Medicine Radioisotopes Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Latin America Nuclear Medicine Radioisotopes Sales YoY (2017-2028) & (K Units)
    Figure 28. Latin America Nuclear Medicine Radioisotopes Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Middle East & Africa Nuclear Medicine Radioisotopes Sales YoY (2017-2028) & (K Units)
    Figure 30. Middle East & Africa Nuclear Medicine Radioisotopes Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. The Nuclear Medicine Radioisotopes Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 32. The Top 5 and 10 Largest Manufacturers of Nuclear Medicine Radioisotopes in the World: Market Share by Nuclear Medicine Radioisotopes Revenue in 2021
    Figure 33. Global Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 34. Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2017-2028)
    Figure 35. Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2017-2028)
    Figure 36. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2017-2028)
    Figure 37. Global Nuclear Medicine Radioisotopes Revenue Market Share by Application (2017-2028)
    Figure 38. North America Nuclear Medicine Radioisotopes Sales Market Share by Type (2017-2028)
    Figure 39. North America Nuclear Medicine Radioisotopes Revenue Market Share by Type (2017-2028)
    Figure 40. North America Nuclear Medicine Radioisotopes Sales Market Share by Application (2017-2028)
    Figure 41. North America Nuclear Medicine Radioisotopes Revenue Market Share by Application (2017-2028)
    Figure 42. North America Nuclear Medicine Radioisotopes Sales Share by Country (2017-2028)
    Figure 43. North America Nuclear Medicine Radioisotopes Revenue Share by Country (2017-2028)
    Figure 44. U.S. Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 45. Canada Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 46. Europe Nuclear Medicine Radioisotopes Sales Market Share by Type (2017-2028)
    Figure 47. Europe Nuclear Medicine Radioisotopes Revenue Market Share by Type (2017-2028)
    Figure 48. Europe Nuclear Medicine Radioisotopes Sales Market Share by Application (2017-2028)
    Figure 49. Europe Nuclear Medicine Radioisotopes Revenue Market Share by Application (2017-2028)
    Figure 50. Europe Nuclear Medicine Radioisotopes Sales Share by Country (2017-2028)
    Figure 51. Europe Nuclear Medicine Radioisotopes Revenue Share by Country (2017-2028)
    Figure 52. Germany Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 53. France Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 54. U.K. Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 55. Italy Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 56. Russia Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 57. Asia Pacific Nuclear Medicine Radioisotopes Sales Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Nuclear Medicine Radioisotopes Revenue Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Nuclear Medicine Radioisotopes Sales Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Nuclear Medicine Radioisotopes Revenue Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Nuclear Medicine Radioisotopes Sales Share by Region (2017-2028)
    Figure 62. Asia Pacific Nuclear Medicine Radioisotopes Revenue Share by Region (2017-2028)
    Figure 63. China Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 64. Japan Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 65. South Korea Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 66. India Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 67. Australia Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 68. Taiwan Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 69. Indonesia Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 70. Thailand Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 71. Malaysia Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 72. Philippines Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 73. Latin America Nuclear Medicine Radioisotopes Sales Market Share by Type (2017-2028)
    Figure 74. Latin America Nuclear Medicine Radioisotopes Revenue Market Share by Type (2017-2028)
    Figure 75. Latin America Nuclear Medicine Radioisotopes Sales Market Share by Application (2017-2028)
    Figure 76. Latin America Nuclear Medicine Radioisotopes Revenue Market Share by Application (2017-2028)
    Figure 77. Latin America Nuclear Medicine Radioisotopes Sales Share by Country (2017-2028)
    Figure 78. Latin America Nuclear Medicine Radioisotopes Revenue Share by Country (2017-2028)
    Figure 79. Mexico Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 80. Brazil Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 81. Argentina Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 82. Middle East and Africa Nuclear Medicine Radioisotopes Sales Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Nuclear Medicine Radioisotopes Revenue Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Nuclear Medicine Radioisotopes Sales Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Nuclear Medicine Radioisotopes Revenue Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Nuclear Medicine Radioisotopes Sales Share by Country (2017-2028)
    Figure 87. Middle East and Africa Nuclear Medicine Radioisotopes Revenue Share by Country (2017-2028)
    Figure 88. Turkey Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 89. Saudi Arabia Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 90. U.A.E Nuclear Medicine Radioisotopes Revenue (2017-2028) & (US$ Million)
    Figure 91. Nuclear Medicine Radioisotopes Value Chain
    Figure 92. Nuclear Medicine Radioisotopes Production Process
    Figure 93. Channels of Distribution
    Figure 94. Distributors Profiles
    Figure 95. Bottom-up and Top-down Approaches for This Report
    Figure 96. Data Triangulation
    Figure 97. Key Executives Interviewed